Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Simple Skin Test Could Revolutionize Diagnosis of Pediatric Eosinophilic Esophagitis

By LabMedica International staff writers
Posted on 10 Jun 2025

Eosinophilic esophagitis (EoE) is a chronic, food allergen-driven condition marked by inflammation and damage to the esophageal lining. More...

Diagnosing EoE in children remains a clinical challenge, especially in those who lack overt symptoms like eczema. Moreover, current diagnostic methods are invasive and lack reliable, non-invasive biomarkers. In a breakthrough development, researchers have identified the skin, specifically its lipid composition, as a potential new diagnostic window for EoE, using a simple skin tape test.

The study, led by researchers at National Jewish Health (Denver, CO, USA), explored whether EoE could be identified through alterations in skin lipids, even in the absence of visible skin conditions like atopic dermatitis. Their approach focused on ceramides, which are lipid molecules critical to the skin’s protective barrier. Using liquid chromatography with tandem mass spectrometry, researchers performed lipidomics analysis on skin tape strip samples collected from the forearms of children enrolled in the study. These tape strips allowed non-invasive access to skin biomarkers. The findings published in the Journal of Allergy and Clinical Immunology reveal that children with EoE but no eczema had significant deficits in long-chain and ultralong-chain ceramides compared to healthy controls.

The results suggest a systemic link between EoE and skin barrier dysfunction, highlighting that EoE and eczema, though affecting different tissues, may stem from similar underlying disruptions in lipid metabolism and epithelial integrity. This opens the door to broader implications for diagnosing and monitoring allergic diseases via skin-based assessments. If validated in future studies, this tape-based skin test could offer a non-invasive, accessible, and cost-effective method for identifying children at risk for EoE — sparing them from more invasive diagnostic procedures like endoscopy.

“This study paves the way for using non-invasive skin tape stripping as a potential diagnostic or screening tool for EoE—eliminating the need for endoscopy,” said Donald Y. Leung, MD, PhD, of National Jewish Health. “By analyzing skin lipid profiles, we may be able to detect epithelial vulnerability before symptoms appear. If validated, this simple skin test could revolutionize how we diagnose and monitor eosinophilic esophagitis.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Urinalysis Solution
UN-9000
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.